Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Itakura

Showing results (111-120 of 123) with videos related to

Pageof 13
Sort By:
Plos One|October 25, 2016
Complex Pattern of Resistance-Associated Substitutions of Hepatitis C Virus after Daclatasvir/Asunaprevir Treatment FailureJun Itakura, Masayuki Kurosaki, Chitomi Hasebe, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 14, 2020
Strategy for advanced hepatocellular carcinoma based on liver function and portal vein tumor thrombosisShun Kaneko, Kaoru Tsuchiya, Yutaka Yasui, et al.
Scientific Reports|August 13, 2020
Impaired brain function improved by L-carnitine in patients with cirrhosis: evaluation using near-infrared spectroscopyHiroyuki Nakanishi, Yuka Hayakawa, Youhei Kubota, et al.
Investigational New Drugs|September 29, 2021
Early experience of atezolizumab plus bevacizumab therapy in Japanese patients with unresectable hepatocellular carcinoma in real-world practiceYuka Hayakawa, Kaoru Tsuchiya, Masayuki Kurosaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 27, 2019
Three criteria for radiological response on survival in patients with hepatocellular carcinoma treated with lenvatinibShun Kaneko, Kaoru Tsuchiya, Masayuki Kurosaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 2, 2018
Real-world efficacy and safety of sofosbuvir + ribavirin for hepatitis C genotype 2: A nationwide multicenter study by the Japanese Red Cross Liver Study GroupTakehiro Akahane, Masayuki Kurosaki, Jun Itakura, et al.
Journal of Gastroenterology|February 20, 2019
Safety and efficacy of glecaprevir and pibrentasvir in Japanese hemodialysis patients with genotype 2 hepatitis C virus infectionGoki Suda, Chitomi Hasebe, Masami Abe, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 27, 2018
Efficacy of daclatasvir plus asunaprevir in patients with hepatitis C virus infection undergoing and not undergoing hemodialysisHideki Fujii, Hiroyuki Kimura, Masayuki Kurosaki, et al.
Journal of Gastroenterology|July 19, 2018
Safety and efficacy of elbasvir and grazoprevir in Japanese hemodialysis patients with genotype 1b hepatitis C virus infectionGoki Suda, Masayuki Kurosaki, Jun Itakura, et al.
Hepatology (Baltimore, Md.)|February 10, 2019
Bezafibrate Improves GLOBE and UK-PBC Scores and Long-Term Outcomes in Patients With Primary Biliary CholangitisAkira Honda, Atsushi Tanaka, Tetsuji Kaneko, et al.
Pageof 13

Showing results (111-120 of 123) with videos related to

Sort By:
Pageof 13
Plos One|October 25, 2016
Complex Pattern of Resistance-Associated Substitutions of Hepatitis C Virus after Daclatasvir/Asunaprevir Treatment FailureJun Itakura, Masayuki Kurosaki, Chitomi Hasebe, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 14, 2020
Strategy for advanced hepatocellular carcinoma based on liver function and portal vein tumor thrombosisShun Kaneko, Kaoru Tsuchiya, Yutaka Yasui, et al.
Scientific Reports|August 13, 2020
Impaired brain function improved by L-carnitine in patients with cirrhosis: evaluation using near-infrared spectroscopyHiroyuki Nakanishi, Yuka Hayakawa, Youhei Kubota, et al.
Investigational New Drugs|September 29, 2021
Early experience of atezolizumab plus bevacizumab therapy in Japanese patients with unresectable hepatocellular carcinoma in real-world practiceYuka Hayakawa, Kaoru Tsuchiya, Masayuki Kurosaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 27, 2019
Three criteria for radiological response on survival in patients with hepatocellular carcinoma treated with lenvatinibShun Kaneko, Kaoru Tsuchiya, Masayuki Kurosaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 2, 2018
Real-world efficacy and safety of sofosbuvir + ribavirin for hepatitis C genotype 2: A nationwide multicenter study by the Japanese Red Cross Liver Study GroupTakehiro Akahane, Masayuki Kurosaki, Jun Itakura, et al.
Journal of Gastroenterology|February 20, 2019
Safety and efficacy of glecaprevir and pibrentasvir in Japanese hemodialysis patients with genotype 2 hepatitis C virus infectionGoki Suda, Chitomi Hasebe, Masami Abe, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 27, 2018
Efficacy of daclatasvir plus asunaprevir in patients with hepatitis C virus infection undergoing and not undergoing hemodialysisHideki Fujii, Hiroyuki Kimura, Masayuki Kurosaki, et al.
Journal of Gastroenterology|July 19, 2018
Safety and efficacy of elbasvir and grazoprevir in Japanese hemodialysis patients with genotype 1b hepatitis C virus infectionGoki Suda, Masayuki Kurosaki, Jun Itakura, et al.
Hepatology (Baltimore, Md.)|February 10, 2019
Bezafibrate Improves GLOBE and UK-PBC Scores and Long-Term Outcomes in Patients With Primary Biliary CholangitisAkira Honda, Atsushi Tanaka, Tetsuji Kaneko, et al.
Pageof 13